Search

Akanksha Nagpal

from Lexington, MA
Age ~49
Get Report
Also known as:
Akanshka Nagpal
Related to:
Rekha NagpalAkanshka Nagpal
Connected to:
Aashish K Nagpal, 29Bobby Nagpal, 65Jaya Nagpal, 46Lalita Nagpal, 78Madhu Nagpal, 78Meenakshi Nagpal, 57Megha Nagpal, 40Mohit Nagpal, 58Nakul Nagpal, 39Parveen Nagpal, 41

Akanksha Nagpal Phones & Addresses

  • Lexington, MA
  • 3040 Covington Pl, Round Rock, TX 78681
  • Cedar Park, TX
  • Fremont, CA
  • Campbell, CA
  • San Jose, CA
  • Atlanta, GA

Work

Company: Icu medical Jun 2018 Position: Senior director - head of iv solutions technology

Education

School / High School: Stanford University School of Medicine

Skills

Protein Purification • Purification • Technology Transfer • Gmp • Protein Chemistry • Downstream Processing • Protein Folding • Biophysics

Industries

Biotechnology

Resumes

Resumes

Akanksha Nagpal Photo 1

Senior Director - Head Of Iv Solutions Technology

View page
Location:
Austin, TX
Industry:
Biotechnology
Work:
Icu Medical
Senior Director - Head of Iv Solutions Technology
Novartis Sep 2010 - May 2013
Principal Scientist
Pfizer Sep 2010 - May 2013
Director For Manufacturing Sciences and Technology and Operational Excellence Groups
Medimmune Jan 2007 - Sep 2010
Scientist Ii
Milliporesigma Apr 2006 - Dec 2006
Research Scientist Iii
Education:
Stanford University School of Medicine
Georgia Institute of Technology
Doctorates, Doctor of Philosophy, Biochemistry Doms, Iit Roorkee
Master of Science, Masters, Biotechnology
Skills:
Protein Purification
Purification
Technology Transfer
Gmp
Protein Chemistry
Downstream Processing
Protein Folding
Biophysics

Publications

Us Patents

Methods For Purification Of Viruses

View page
US Patent:
20120219588, Aug 30, 2012
Filed:
Sep 24, 2009
Appl. No.:
13/120638
Inventors:
Mark Thompson - Morgan Hill CA, US
Janice Wee - San Mateo CA, US
Akanksha Nagpal - San Jose CA, US
International Classification:
A61K 39/155
A61P 31/14
A61P 37/04
C12N 7/02
C12N 7/00
US Classification:
4242111, 435239, 4352351
Abstract:
The present invention provides methods for the purification of cell-associated viruses from adherent cells (e.g., MDCK or Vero cells). In particular, the present invention provides purification methods for the production of immunogenic compositions comprising a live attenuated cell-associated virus (e.g., an attenuated respiratory syncytial virus (RSV) or cold-adapted, and/or temperature sensitive influenza virus) that result in levels of host cell DNA (HCD), host cell protein (HCP) and non-specific endonuclease (e.g., Benzonase), which are below the specifications required by regulatory agencies. The immunogenic compositions can be used to actively immunize subjects or to generate antibodies for a variety of uses, including passive immunization and diagnostic immunoassays.
Control profile
Akanksha Nagpal from Lexington, MA, age ~49 Get Report